ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial.
Hu Y, Li H, Zhang H, Chen X, Chen J, Xu Z, You H, Dong R, Peng Y, Li J, Li X, Wu D, Zhang L, Cao D, Jin H, Qiu D, Yang A, Lou J, Zhu X, Niu J, Ding Y.
Hu Y, et al. Among authors: wu d.
Nat Commun. 2023 Oct 12;14(1):6409. doi: 10.1038/s41467-023-42162-0.
Nat Commun. 2023.
PMID: 37828034
Free PMC article.
Clinical Trial.